Coronavirus Digest: Pfizer Half Half of Vaccine Supply News | W.

  Coronavirus Digest: Pfizer Half Half of Vaccine Supply News |  W.

US pharma giant Pfizer That said Will deliver 50 million doses This year Its Covid-19 vaccineIs, which was developed by a German firm Biotech. The new forecast represents half of the firm’s original 100 million dosesLtd. A company spokesman told the US newspaper that the delivery is expected The Wall Street Journal.

Pfizer blames supply chain problems for reducing its delivery targets iIt took longer than expected to increase the supply of raw materials. Pay firm added that The results of the medical study were available later than expected, Which also played a role in halving the delivery target.

The bayonet tech-Pfizer vaccine is said to be 95% Effective against Coronavirus and the first country in the Western world to do so has already been approved by the UK.

WA has furthered the most important development in the world.

read more: Taking a test shot of Russia’s Sputnik V COVID-19 vaccine


Multinational Technical Pay IBM Warned that the companies involved in vaccine distribution had unleashed a number of possible cyber attacks by actors in the state. IBMA said the European Commission’s Directorate General for Taxation and Customs Union was a target, as well as European and Asian companies that have not been disclosed.

US: President-elect Joe Biden said Thursday that he would voluntarily take a vaccine and that U.S. Infectious diseases specialist Dr. Anthony decided to keep Fawcett in his current role.

Biden added that he would ask Americans to commit to wearing a mask for 100 days as his first act as president in place of a short-term president of a nationwide mandate.

See also  Beattie thinks about the suspicious circumstances that ended her contract

U.S. pharma giant Moderna plans to make more than 100 million doses of its Covid-19 vaccine available in the first quarter of 2021, adding that by the end of this year, U.S. Is expected to be available in 20 million doses.

read more: UN: Covid-19 to worsen poverty in 47 poor countries

Costa rica: The Central American nation signed an agreement with Bayonet Tech-Pfizer to produce and deliver millions of vaccines next year, the office of President Carlos Alvardo said Thursday.

A statement from the president’s office stated that the “initial agreement reached in October will be implemented during the year.” With agreements with AstraZeneca and Kovacs, about 60% of the country’s population will be vaccinated by the end of 2021.


South Korea: Some 629 new COVID cases were reported in South Korea in the previous 24 hours, the highest daily increase in nine months despite strict restrictions on movement of people.

The mayor of the capital, Seoul, CO Jeong-hype, announced that most of the centers in the city would be closed by 9pm starting Saturday.


Austria: Voluntary mass testing has begun in Vienna and the West Warrerburg and Tyrol subwins. The procedure involves rapid antigen tests, if they come out positive, will be confirmed by more conventional testing within 24 hours.

The country plans to begin ending its tight lockdown in a few days and hopes that mass testing with the support of the mass Strian forces will prevent further tough lockdowns in the future.

Germany: The number of coronavirus patients in intensive care units has exceeded 4,000 for the first time since the onset of the epidemic.

See also  Scottish government wants independence referendum before the end of 2023

A total of about 31 new patients were transferred to the ICU, taking the total number to 4,011. According to official counts, 5,000 intensive care beds are kept free in Germany.

Health Minister Jens Spah has called for additional restrictions to prevent the spread of choroid virus in some parts of Germany, which has a very high number of Covid-19 infections.

The Robert Koch Institute’s daily report states that there are 23,449 new coronavirus infections in Germany and 432 people have died from the virus.

JCG, KBD / RT (AP, AFP, DPA, Reuters)


Please enter your comment!
Please enter your name here